Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Sinopharm Group Co., Ltd.    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinopharm : Nine-Month Net Profit Rose 7.9%

10/22/2020 | 08:13pm EST

By Justina Lee

Sinopharm Group Co.'s net profit for the nine months ended September rose 7.9% from a year earlier, helped by higher total operating revenue.

The drug seller posted net profit of 4.96 billion yuan ($742 million) for the period, compared with 4.60 billion yuan a year earlier.

Total operating revenue rose 4.8% to CN327.61 billion from CNY312.69 billion a year ago, said the Chinese company, which mainly engages in the distribution of pharmaceutical and healthcare products.

Write to Justina Lee at justina.lee@wsj.com

(END) Dow Jones Newswires

10-22-20 2012ET

Stocks mentioned in the article
ChangeLast1st jan.
SINOPHARM GROUP CO., LTD. 0.00% 19.74 End-of-day quote.-30.62%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) 0.05% 6.56689 Delayed Quote.-5.54%
All news about SINOPHARM GROUP CO., LTD.
11/25GLOBAL MARKETS LIVE: IBM to cut 10,000 jobs in Europe, Tesla recalls 9,500 ve..
11/23Brazil has enough infection data to analyze Sinovac's COVID-19 vaccine - offi..
RE
11/23Sao Paulo expects regulator approval for Sinovac vaccine by January
RE
11/18Chinese Covid Vaccine Gives Scientists Pause Over Antibody Levels in Early Tr..
DJ
11/17Sinovac's COVID-19 vaccine induces quick immune response - study
RE
11/13Indonesian ministers say early vaccination campaign will use china's sinovac,..
RE
11/11SINOPHARM : China's Sinopharm says data 'better than expected" from unit's COVID..
RE
11/10Brazil regulator says suspension of Sinovac COVID-19 vaccine was technical
RE
11/09GRAPHIC : Tracking the vaccine race
RE
11/09FACTBOX : COVID-19 vaccine frontrunners
RE
More news
Financials
Sales 2020 459 B 69 801 M 69 801 M
Net income 2020 6 831 M 1 039 M 1 039 M
Net Debt 2020 20 106 M 3 058 M 3 058 M
P/E ratio 2020 7,51x
Yield 2020 3,98%
Capitalization 52 200 M 7 937 M 7 940 M
EV / Sales 2020 0,16x
EV / Sales 2021 0,14x
Nbr of Employees 93 764
Free-Float 43,0%
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 22,93 CNY
Last Close Price 16,75 CNY
Spread / Highest target 116%
Spread / Average Target 36,9%
Spread / Lowest Target 3,06%
EPS Revisions
Managers
NameTitle
Yong Liu President & Executive Director
Fang Yao Chairman-Supervisory Board
Zhi Ming Li Chairman
Xiu Chang Jiang Chief Financial Officer & Vice President
Jin Dong Deng Non-Executive Director
Sector and Competitors